BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10612173)

  • 1. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI
    Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
    Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osmotic activity of plasma in plasmapheresis in patients with multiple myeloma].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI; Zhuravlev VS; Zakharova ES; Khoroshko ND
    Ter Arkh; 2001; 73(2):57-60. PubMed ID: 11338858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood volume and hematocrit value in macroglobulinemia and myeloma.
    Kopp WL; MacKinney AA; Wasson G
    Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV; Gorodetskiĭ VM
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of plasmapheresis in surgical hematology].
    Abdulkadyrov KM; Shatrov VA; Katsadze IuL
    Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma viscosity changes after sham plasmapheresis.
    Jakoet A; Martell RW; Jacobs P
    Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
    Usnarska-Zubkiewicz L
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integral viscosity: a useful parameter in evaluating whole blood and plasma viscosities in health and disease.
    Girolami A; Martino R; Procidano M; Saltarin P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):488-94. PubMed ID: 6182069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effects of plasmapheresis in Waldenström's disease].
    Moulinier J; Servantie X; Mesnier F
    J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704
    [No Abstract]   [Full Text] [Related]  

  • 19. Simplified method for estimation of serum and plasma viscosity in multiple myeloma and related disorders.
    Wright DJ; Jenkins DE
    Blood; 1970 Oct; 36(4):516-22. PubMed ID: 4195432
    [No Abstract]   [Full Text] [Related]  

  • 20. Removal and recovery rate of paraproteins by plasma exchange.
    Busnach G; Perrino ML; Dal Col A; Brando B; Minetti L
    Life Support Syst; 1983; 1 Suppl 1():112-4. PubMed ID: 6443836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.